{"nct_id":"NCT05070390","title":"A Study of Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007)","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2021-11-16","start_date_type":"ACTUAL","primary_completion_date":"2023-05-03","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}